Plain-English translation of NCT05691608 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
MAPPYACTS 2 is an international study that examines the genetic makeup of your cancer using a tumor sample or blood sample. By understanding your cancer's unique genetic profile, doctors can recommend targeted treatments that are most likely to work for you specifically, either through experimental trials or precision medicine programs designed just for your situation.
When childhood and young adult cancers come back or stop responding to standard treatments, doctors need better ways to find what will work next. This study exists to create a comprehensive genetic database and connect patients with the most promising treatment options based on their individual cancer's genetics.
You likely qualify if…
You likely don't qualify if…
You will provide a tumor biopsy, surgical sample, bone marrow sample, blood sample, or previously stored tumor tissue for genetic testing. A team of doctors and scientists will analyze your cancer's genes and discuss your results in a molecular tumor board to recommend personalized treatment options. The study will then follow your medical care and outcomes to learn how well the recommended treatments work for you and other patients.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
France